Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy
Authors:
- G. RossGRG. Ross
- C.C. LimCLC.C. Lim
- S. AshleySAS. Ashley
- D. GoodeDGD. Goode
- D. TraishDTD. Traish
- M. BradaMBM. Brada
- 1 January 1994
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 30 (12) , 1809-1815
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study)Radiotherapy and Oncology, 1993
- Selection bias, survival, and brachytherapy for gliomaJournal of Neurosurgery, 1992
- Prognostic factors for high-grade malignant glioma: Development of a prognostic indexJournal of Neuro-Oncology, 1990
- Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990
- Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytomaBritish Journal of Cancer, 1988
- Successful chemotherapy for recurrent malignant oligodendrogliomaAnnals of Neurology, 1988
- Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group studyCancer, 1983
- Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group studyJournal of Neuro-Oncology, 1983